Dr. Coleman is an assistant professor of pharmacy practice and director of the pharmacoeconomics and outcomes studies group at the University of Connecticut School of Pharmacy.
What should the preceptor tell the pharmacy student?
EM, a 57-year-old Hispanic woman, comes for a follow-up visit at her primary care clinic. There she sees her primary care physician (PCP) and a consulting pharmacist. The PCP asks the pharmacist if EM could take any other medications that would improve her chances of a longer life. The pharmacist discerns that EM has a 10-year history of stable angina pectoris, has never had a myocardial infarction, and has a normal ejection fraction at 64%. Her chest pain is well-controlled on metoprolol 50 mg twice daily and amlodipine 10 mg once daily with nitroglycerin tablets for acute angina attacks. She receives aspirin 162.5 mg daily and pravastatin 40 mg daily (low-density lipoprotein cholesterol 72 mg/dL).
Given this information, should another therapy be added to EM’s medical regimen?
In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine
Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.
News from the year's biggest meetings
Clinical features with downloadable PDFs